1. Home
  2. IRD vs NSYS Comparison

IRD vs NSYS Comparison

Compare IRD & NSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRD
  • NSYS
  • Stock Information
  • Founded
  • IRD 2018
  • NSYS 1981
  • Country
  • IRD United States
  • NSYS United States
  • Employees
  • IRD N/A
  • NSYS N/A
  • Industry
  • IRD
  • NSYS Industrial Machinery/Components
  • Sector
  • IRD
  • NSYS Technology
  • Exchange
  • IRD NYSE
  • NSYS Nasdaq
  • Market Cap
  • IRD 36.1M
  • NSYS 29.0M
  • IPO Year
  • IRD N/A
  • NSYS N/A
  • Fundamental
  • Price
  • IRD $1.22
  • NSYS $10.80
  • Analyst Decision
  • IRD Strong Buy
  • NSYS
  • Analyst Count
  • IRD 1
  • NSYS 0
  • Target Price
  • IRD $8.00
  • NSYS N/A
  • AVG Volume (30 Days)
  • IRD 149.1K
  • NSYS 5.5K
  • Earning Date
  • IRD 02-19-2025
  • NSYS 03-19-2025
  • Dividend Yield
  • IRD N/A
  • NSYS N/A
  • EPS Growth
  • IRD N/A
  • NSYS 109.80
  • EPS
  • IRD N/A
  • NSYS 1.55
  • Revenue
  • IRD $8,381,000.00
  • NSYS $135,567,000.00
  • Revenue This Year
  • IRD N/A
  • NSYS N/A
  • Revenue Next Year
  • IRD $29.37
  • NSYS N/A
  • P/E Ratio
  • IRD N/A
  • NSYS $6.74
  • Revenue Growth
  • IRD N/A
  • NSYS N/A
  • 52 Week Low
  • IRD $0.81
  • NSYS $9.53
  • 52 Week High
  • IRD $2.77
  • NSYS $19.15
  • Technical
  • Relative Strength Index (RSI)
  • IRD N/A
  • NSYS 57.14
  • Support Level
  • IRD N/A
  • NSYS $9.84
  • Resistance Level
  • IRD N/A
  • NSYS $10.38
  • Average True Range (ATR)
  • IRD 0.00
  • NSYS 0.34
  • MACD
  • IRD 0.00
  • NSYS 0.07
  • Stochastic Oscillator
  • IRD 0.00
  • NSYS 83.74

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA) and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical and manufacturing services and support including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense and Industrial markets with key revenue coming from Medical device and product manufacturing and related engineering services.

Share on Social Networks: